GlassScriptPhysician profile
Lindsey Yates Hicks
NPI 1730579251
$3,096.57
in general payments reported to CMS, 2019-2025
14 companies · $447 in 2025
The $447 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $940 · 2022: $583 · 2023: $787 · 2024: $340 · 2025: $447.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,573.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,573.46 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $1,421.11 | 2023-2025 | |
| Allergan, INC. | $1,388.14 | 2021-2022 | |
| Access Pro Medical, LLC | $50.11 | 2023 | Matriderm |
| Novartis Pharmaceuticals Corporation | $44.34 | 2021-2022 | |
| Mentor Worldwide LLC | $37.26 | 2023 | Mentor Cpx 2 Breast Tissue Expander, Mentor Memorygel Resterilizable Gel Sizer |
| Integra Lifesciences Corporation | $30.51 | 2021 | |
| Kerecis Limited | $19.43 | 2025 | Kerecis Surgiclose, Kerecis Graftguide |
| Tela Bio, INC. | $16.67 | 2022 | |
| Genentech USA, INC. | $16.48 | 2024 | Erivedge |
| Genzyme Corporation | $15.92 | 2021 | |
| Becton, Dickinson and Company | $15.60 | 2025 | Arista |
| Regeneron Healthcare Solutions, INC. | $15.39 | 2021 | |
| Kowa Pharmaceuticals America, INC. | $13.47 | 2023 | Seglentis |
| Galderma Laboratories, L.P. | $12.14 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Lindsey Hicks listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.